It is well established that CD4 T cells play a central role in defense against viral infections. During viral infections, not only are CD4 T cells required for inducing effective antibody responses, effector CD4 T cells can exert direct antiviral effects by producing cytokines like gamma interferon (IFN-␥) and tumor necrosis factor alpha (TNF-␣) (5, 9, 18, 19, 29, 62) . Additionally, CD4 T cells are required for the elicitation and/or maintenance of optimal CD8 T-cell responses. While primary CD8 T-cell responses to lymphocytic choriomeningitis virus (LCMV) and ectromelia virus do not require CD4 T-cell help, induction of CD8 T-cell responses to vesicular stomatitis virus, influenza virus, and herpes simplex virus are CD4 T-cell dependent (2, 17, 35, 59) . In contrast to acute viral infections, CD4 T cells are uniformly essential for sustaining CD8 T-cell responses during chronic viral infections (8, 35, 46, 47, 59) . During chronic viral infections, CD4 T-cell deficiency leads to rapid loss of CD8 T-cell activity and uncontrolled viral replication (19, 35, 46) . In acute viral infections like LCMV, although the initial induction of CD8 T-cell responses is independent of CD4 T cells, the long-term maintenance of functional memory CD8 T cells requires CD4 T-cell help (4, 10, 51, 54) . Taken together, these reports provide unequivocal evidence that CD4 T cells play a critical role in orchestrating all facets of the antiviral humoral and cellular immune responses. Thus, it is of paramount importance to understand the mechanisms that regulate the antiviral CD4 T-cell response for purposes of rational design of vaccines and development of immunotherapeutic modalities.
In viral infections, although effector CD4 T cells seem to produce predominantly IFN-␥, interleukin-2 (IL-2), and TNF-␣, CD4 T cells that secrete IL-4 and IL-5 are often detectable (3, 13, 22, 44, 57, 58) . There is accumulating evidence that effector molecules like IFN-␥ and TNF-␣ might have important roles in regulation of mature T-cell homeostasis (23) . In chronic intracellular bacterial infections, IFN-␥ and TNF-␣ have been shown to down regulate CD4 T-cell responses (15, 60) , while deficiency of IFN-␥ or TNF-␣ leads to enhanced expansion of CD4 T cells and exacerbation of experimental autoimmune encephalitis in mice (11, 26) . TNF-␣ also exerts potent immunosuppressive effects in protection against T-cell-dependent autoimmune pathologies (14) . However, the mechanism(s) underlying the regulation of CD4 Tcell responses by TNF is not well understood. In this study, we have investigated the role of TNF in regulating various phases (expansion, contraction, and memory phases) of the CD4 Tcell response in vivo by use of a well-characterized mouse model of acute LCMV infection. We show that TNF receptors (TNFRs) play a negative role in regulating expansion of CD4 T cells and the subsequent development of CD4 T-cell memory. Mechanistic studies suggested that the down regulatory functions of TNFRs on CD4 T-cell expansion are mediated at least in part by indirect effects on accessory cells, like dendritic cells and macrophages. Thus, modulation of TNF-mediated effects may be a viable approach to improve the magnitude of T-cell memory during vaccinations or down regulate CD4 Tcell-dependent immunopathology.
(Memorial-Sloan Kettering Cancer Center, NY) (34) . SMARTA T-cell-receptor transgenic (TCR Tg) mice (40, 41) were provided by Pamela Ohashi (University of Toronto, Canada), with permission from Hans Hengartner and Annette Oxenius (University of Zurich, Switzerland). SMARTA transgenic mice were backcrossed to the Thy1.1 background at the University of Wisconsin. Congenic Thy1.1 (B6.PL-Thy1a) mice and Rag1-deficient (Rag1 Ϫ/Ϫ ) mice on the C57BL/6 background were purchased from Jackson Laboratories. Experimental mice were used at 6 to 8 weeks of age. All animal experiments were performed according to the strict guidelines of the Institutional Animal Care and Use Committee.
Virus. Mice were injected intraperitoneally with 2 ϫ 10 5 PFU of the Armstrong strain of LCMV to induce an acute infection. Infectious LCMV in the tissues was quantitated by a plaque assay done with Vero cells, as described previously (1) .
Flow cytometry. Single-cell suspensions of splenocytes were stained with anti-CD4, anti-CD44, anti-Thy1.1, and anti-Thy1.2 antibodies in fluorescence-activated cell sorting buffer (phosphate-buffered saline containing 2% bovine serum albumin and 0.1% sodium azide) for 30 min at 4°C. Following staining, cells were fixed in 2% paraformaldehyde and data were acquired using a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). Fluorescence-activated cell sorting data were analyzed using CellQuest (Becton Dickinson) or FlowJo (Tree Star, Inc.) software. All antibodies were purchased from BD-Pharmingen (San Diego, CA) unless mentioned otherwise.
Quantification of LCMV-specific CD4 T cells by intracellular cytokine staining. In LCMV-infected C57BL/6 mice, CD4 T cells recognize the amino acid residues 61 to 80 in the LCMV glycoprotein (here designated GP61) presented by the major histocompatibility complex class II molecule I-A b . The number of GP61-specific CD4 T cells in the spleen was enumerated by intracellular cytokine staining, as described elsewhere (58) . Briefly, splenocytes were stimulated with GP61 peptide for 5 h in the presence of brefeldin A. After the 5-h stimulation, cells were stained for cell surface CD4 and intracellular IFN-␥, TNF-␣, and IL-2 by use of a Cytofix/Cytoperm kit (BD-Pharmingen). In some experiments, cells were also stained for cell surface Thy1.1, Thy1.2, CD44, CD11a, and CD127 (eBioscience, San Diego, CA) molecules. Stained cells were fixed in 2% paraformaldehyde and acquired on a flow cytometer (FACSCalibur; Becton Dickinson), and data were analyzed using CellQuest or FlowJo software.
Adoptive transfer of transgenic CD4 T cells. Single-cell suspensions of splenocytes from SMARTA TCR Tg mice, containing 10 5 TCR Tg T cells, were adoptively transferred (52) into wt and DKO mice by intravenous injection. Twenty-four hours after cell transfer, mice were infected with LCMV, and the expansion of transgenic T cells was assessed on the eighth day after infection. In some experiments, T cells purified from naïve SMARTA TCR Tg mice were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes) and adoptively transferred into mice that were infected with LCMV 3 days before cell transfer. The proliferation of adoptively transferred SMARTA TCR Tg cells was assessed 72 h later by flow cytometry.
Isolation and characterization of dendritic cells in the spleen. Single-cell suspensions of splenocytes were prepared by treatment with collagenase D (Roche Applied Science, Indianapolis, IN), as described previously (39) . Splenocytes were stained with anti-CD11c and anti-B220 antibodies and analyzed by flow cytometry as described above. 
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Staining for apoptotic cells by TUNEL. Formaldehyde-fixed sections from the spleens of LCMV-infected wt and DKO mice were stained for apoptotic nuclei by use of a fluorescein in situ cell death detection kit (Roche Applied Science, Indianapolis, IN) per the recommendations of the manufacturer. To colocalize apoptotic nuclei and dendritic cells, terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) staining (green) was followed by incubations with biotinylated anti-mouse CD11c (eBioscience) and then streptavidin-Alexa 568 conjugate (Molecular Probes). Nonspecific binding of antibodies was blocked with bovine serum albumin and mouse serum before staining for CD11c was done.
Construction of bone marrow chimeric mice. Bone marrow cells were prepared by flushing femurs from wt and DKO mice with RPMI media and depleted of T cells by use of anti-CD5 microbeads (Miltenyi Biotec, Auburn, CA). 
RESULTS
Primary CD4 T-cell response to LCMV is enhanced in TNFR-deficient mice. Infection of immunocompetent mice with the Armstrong strain of LCMV elicits a potent primary CD8 and CD4 T-cell response (37, 53) , and the virus is cleared in 8 to 10 days. To examine the role of TNFRs in regulating primary CD4 T-cell responses during an acute viral infection, groups of wt, p55 Ϫ/Ϫ , p75 Ϫ/Ϫ , and DKO mice were infected with LCMV. On day 8 postinfection (p.i.), we assessed virusinduced activation of CD4 T cells in the spleen by quantifying the number of CD4 ϩ CD44 hi T cells by flow cytometry. As shown in Fig. 1A , the absolute numbers of activated CD4 T cells in the spleens of p55 Ϫ/Ϫ or p75 Ϫ/Ϫ mice were slightly higher than those in the spleens of wt mice. Strikingly, spleens of DKO mice contained a significantly (P Ͻ 0.00001) larger number of activated CD4 T cells than the spleens of wt, p55 Ϫ/Ϫ , and p75 Ϫ/Ϫ mice. These data indicate that TNFRs suppress activation of CD4 T cells during an acute viral infection.
Next, we compared primary CD4 T-cell responses to the I-A b -restricted LCMV epitope GP61 between wt and TNFRdeficient mice by intracellular cytokine staining ( Ϫ/Ϫ and p75 Ϫ/Ϫ mice were each Ͻ2-fold greater than those in the spleens of wt mice. In striking contrast, the total numbers of GP61-specific CD4 T cells in the spleens of DKO mice were fourfold higher (P Ͻ 0.00001) than those in the spleens of wt mice. The enhanced CD4 T-cell activation seen with DKO mice was not likely to be induced by higher viral load in the tissues, since TNFR deficiency did not affect either the magnitude or the kinetics of LCMV replication (Fig.  1D) .
The two ligands that are known to interact with TNFRs are TNF-␣ and lymphotoxin alpha (56) . To determine whether the enhanced primary CD4 T-cell expansion in DKO mice was due to a lack of TNF-␣-mediated effects, we infected wt and TNF Ϫ/Ϫ mice with LCMV and assessed primary LCMV-specific CD4 T-cell responses in the spleens on day 8 p.i. As shown in Fig. 2 , total numbers of GP61-specific CD4 T cells in the spleens of TNF Ϫ/Ϫ mice were fourfold higher (P Ͻ 0.05) than those in the spleens of wt mice. These findings, along with data shown in Fig. 1A to C, suggested that TNF-␣/TNFR interactions down regulate the expansion of antigen-specific CD4 T cells during an acute LCMV infection.
TNFR-expressing transgenic CD4 T cells expand more in a TNFR-deficient lymphoid environment. The data presented above showed a greater expansion of LCMV-specific CD4 T cells in DKO mice than in wt mice. Here we have investigated the importance of TNFRs on CD4 T cells versus non-CD4 T cells in down regulation of virus-specific CD4 T-cell responses. To this end, we adoptively transferred 10 5 TNFR-sufficient naïve SMARTA CD4 T cells that express the transgenic class II-restricted TCR specific to the GP61 epitope of LCMV into wt and DKO mice. Following adoptive transfer, recipients were infected with LCMV, and the expansion of transgenic CD4 T cells was assessed on day 8 p.i. The adoptively transferred transgenic SMARTA CD4 T cells were distinguished from the host CD4 T cells based on Thy1.1 expression: while host T cells were Thy1.2 ϩ , the donor transgenic T cells were Thy1.1 ϩ . As shown in Fig. 3 , the frequencies and total numbers of Thy1.1 ϩ GP61-specific transgenic CD4 T cells were Ͼ2.5-fold higher (P Ͻ 0.07) in DKO recipients than in wt recipients. The numbers of SMARTA CD4 T cells in the spleens of control uninfected wt and DKO mice were comparable (data not shown). Thus, the activation and expansion of TNFRsufficient CD4 T cells were greater in a TNFR-deficient lymphoid environment. These findings indicated that TNFR sig- naling in non-CD4 T cells could suppress the expansion of virus-specific CD4 T cells during an acute viral infection.
A role for TNFRs in the depletion of CD11c hi non-pDCs in LCMV-infected mice. It has been shown previously that TNF can inhibit the responses and/or viability of dendritic cells in vitro (6, 42) . Therefore, it is possible that enhanced expansion of LCMV-specific CD4 T cells in TNFR-deficient mice could be due to a lack of TNF-induced inhibitory effect on the dendritic cells. To address this issue, we characterized the effect of TNFR deficiency on the dynamics of LCMV-induced alterations in the CD11c ϩ dendritic cell populations. As illustrated in Fig. 4 , spleens of uninfected wt, p55 Ϫ/Ϫ , p75 Ϫ/Ϫ , and DKO mice contained comparable percentages of plasmacytoid dendritic cells (pDCs) (CD11c lo B220 ϩ ) and nonplasmacytoid dendritic cells (non-pDCs) (CD11c hi B220 Ϫ ). As reported by Montoya et al. (36) , the percentages of non-pDCs showed a profound drop on day 2 p.i. (data not shown) and day 3 p.i. in wt mice compared to the percentages of non-pDCs in uninfected mice; the percentages of non-pDCs in wt mice dropped from ϳ2.5% (uninfected mice) to 0.37% Ϯ 0.06% on day 3 p.i. In striking contrast, the percentages of non-pDCs in the spleens of LCMV-infected p55 Ϫ/Ϫ (2.56% Ϯ 1%) and DKO (2.6% Ϯ 0.32%) mice were comparable to those in the respective uninfected mice. Importantly, the percentages of nonpDCs in the spleens of LCMV-infected wt mice on day 3 p.i. were significantly (P ϭ 0.001) lower than those in the spleens of DKO mice. Compared to levels for wt mice, LCMV-induced deletion of non-pDCs was modestly affected in p75 Ϫ/Ϫ mice. Unlike for non-pDCs, TNFR deficiency did not significantly (P Ͻ 0.05) alter the LCMV-induced increase in the frequencies of pDCs in the spleen. However, especially on day 3 p.i., a larger proportion of pDCs in DKO mice than in wt mice tended to express lower levels of B220. We also examined the effect of TNFR deficiency on the relative proportions of CD11b ϩ CD11c low and CD11b ϩ CD11c Ϫ macrophages in the spleens on day 3 p.i. At this time point, the percentages of CD11b ϩ CD11c low (3.9% Ϯ 0.8%) and CD11b ϩ CD11c Ϫ (3.7% Ϯ 0.3%) macrophages in the spleens of DKO mice were two-to threefold higher than those in the spleens of wt mice; the observed Previous work has shown that LCMV infection induces apoptosis of splenocytes during the first 3 days after infection, and, importantly, a substantial fraction of these apoptotic cells appear to be CD11c ϩ dendritic cells (36) . Furthermore, it was recently reported that T-cell-derived TNF induced apoptosis of dendritic cells in vitro (6) . To determine the effect of TNFR deficiency on the apoptosis of splenocytes in LCMV-infected mice, we performed TUNEL staining on spleen sections from wt and DKO mice on day 3 p.i. Very few TUNEL ϩ cells were detected in the spleens of uninfected wt and DKO mice (data not shown). Figure 5 shows staining for TUNEL ϩ cells in the spleens of LCMV-infected wt and DKO mice on day 3 p.i. The micrographs in Fig. 5 illustrate that the number of TUNEL ϩ cells in the spleens of DKO mice were considerably lower than those in the spleens of wt mice. We quantitated TUNEL ϩ apoptotic cells by counting five random fields in the spleen sections from day 3-infected wt and DKO mice. The numbers of TUNEL ϩ cells in the DKO mice (130 Ϯ 28) were substantially less than those in the wt mice (443 Ϯ 115). Next, by costaining for CD11c, we examined whether dendritic cells were among the TUNEL ϩ cells in the spleen. Approximately 37% of the TUNEL ϩ cells were CD11c ϩ in the spleens of wt mice. In the DKO mice, not only were the numbers of TUNEL ϩ cells fewer than the numbers in wt mice (Fig. 5 ), only ϳ6% of these cells were CD11c ϩ . These data suggest that TNF/TNFR interactions might be linked causally to the occurrence of cellular apoptosis in the spleen during the early phase of an acute LCMV infection. In summary, based on the data presented in Fig. 4 and 5, we theorize that TNFRs might down regulate antigen-driven expansion of CD4 T cells by limiting the life span of dendritic cells (25) .
Increased proliferation of transgenic CD4 T cells in LCMVinfected TNFR-deficient mice. The data presented in Fig. 4 and 5 suggested that TNFR deficiency resulted in increased survival of the non-pDCs in LCMV-infected mice. It is well established that CD11c ϩ dendritic cells are primarily but not exclusively responsible for presenting antigen to naïve T cells in viral infections (16) . Here we examined whether higher percentages of non-pDCs in DKO mice on day 3 p.i. were associated with enhanced antigen-induced proliferation of LCMV-specific CD4 T cells. We adoptively transferred 5 ϫ 10 5 CFSE-labeled SMARTA Tg T cells into groups of wt and DKO mice on day 3 p.i. As controls, we transferred CFSElabeled SMARTA Tg T cells into uninfected wt and DKO mice. The adoptively transferred SMARTA Tg CD4 T cells were distinguished from the host CD4 T cells based on Thy1.1 expression; while the host T cells were Thy1.2 ϩ , the donor T cells were Thy1.1 ϩ . Proliferation of Thy1.1 ϩ donor transgenic cells was assessed 72 h after T-cell transfer by quantitating CFSE fluorescence by flow cytometry. As shown in Fig. 6A , donor CD4 T cells remained CFSE hi and did not proliferate upon transfer into uninfected wt or DKO mice. Data in Fig. 6A also show that SMARTA TCR Tg CD4 T cells proliferated in both LCMV-infected wt and DKO mice. However, SMARTA Tg cells proliferated more in DKO mice than in wt mice; in the DKO mice, 76% Ϯ 2% of SMARTA CD4 T cells underwent Ͼ5 divisions, compared to 58% Ϯ 5% in wt mice. Consequently, a larger percentage (40% Ϯ 5%) of SMARTA CD4 T cells underwent Ͻ5 divisions in wt mice than in DKO mice (21% Ϯ 2%). These data show that enhanced cellular proliferation was at least in part responsible for increasing the number of LCMV-specific CD4 T cells during the primary response to LCMV.
Next, we examined the activation-induced down regulation of CD62L on the donor transgenic CD4 T cells transferred into wt and DKO recipients. As expected, donor Thy1.1 ϩ cells transferred into uninfected wt and DKO recipients remained CD62L hi . Upon transfer into infected wt mice, 43% Ϯ 11% of the donor TCR Tg cells lost CD62L expression, compared to 72% Ϯ 14% in DKO mice (Fig. 6B) . Collectively, data in Fig.  6A and B suggest that antigen-driven proliferation and differentiation of naïve CD4 T cells into effectors are enhanced in a TNFR-deficient environment. Fig. 3, 4 , and 6 indicate that TNFRs could down regulate expansion of CD4 T cells by indirect effects on non-CD4 T cells. To study whether TNFRs regulate CD4 T-cell responses by direct effects on T cells, we generated mixed bone marrow chimeras by reconstituting lethally irradiated Rag1 Ϫ/Ϫ mice with bone marrow cells from wt/Thy1.1 and DKO/Thy1.2 mice at a 1:1 ratio. Six weeks after bone marrow transfer, we examined the reconstitution of the lymphoid system in Rag1 Ϫ/Ϫ recipients. The wt and DKO T cells in the peripheral blood were distinguished based on expression of the congenic markers Thy1.1 and Thy1.2, respectively. The dot plots in Fig. 7A show the relative proportions of wt/Thy1.1 and DKO/Thy1.2 CD4 T cells in the peripheral blood samples from two representative chimeric mice out of eight examined. These chimeric mice were infected with LCMV, and the CD4 T-cell responses were examined 8 days later. As shown in Fig. 7B and D, on day 8 p.i., the relative proportions of wt/Thy1.1 and DKO/Thy1.2 CD4 T cells mirrored preinfection ratios. Additionally, the relative proportions of wt Thy1.1 ϩ and DKO Thy1.2 ϩ LCMV-specific CD4 T cells (Fig. 7C) did not differ substantially from preinfection values for CD4 T cells. It is possible that there could be differences in precursor frequencies of LCMV-specific CD4 T cells in the wt and DKO T-cell repertoires. We addressed this issue by quantitating the percentages of LCMV-specific CD4 T cells among wt/Thy1.1 and DKO/Thy1.2 CD4 T cells. The data shown in Fig. 7E clearly indicate that the percentages of LCMV-specific CD4 T cells among wt and DKO CD4 T cells were comparable. These data suggest that TNFR-deficient CD4 T cells might not have a selective advantage over wt T cells during the expansion phase of LCMV. Thus, TNF does not appear to regulate CD4 T-cell responses by direct effects on T cells during an acute LCMV infection.
Indirect regulation of CD4 T cells by TNFRs during an acute LCMV infection. Data presented in
Memory CD4 T-cell homeostasis in LCMV-infected TNFRdeficient mice. To investigate the effect of TNFR deficiency on overall CD4 T-cell homeostasis, groups of wt, p55 Ϫ/Ϫ , p75 Ϫ/Ϫ , and DKO mice were infected with LCMV. Between 55 and 60 days after infection, we assessed the relative proportions of naïve and activated/memory cells in the CD4 T-cell compartment by using the well-studied cell surface markers CD44 and CD62L. The dot plots in Fig. 8A show that the relative proportion of activated/memory (CD44 hi ) cells among CD4 T cells is increased in DKO mice compared to the level in wt mice. The ratios of naïve (CD44 lo ) to activated/memory (CD44 hi ) CD4 T cells in the spleens of wt, p55 Ϫ/Ϫ , p75 Ϫ/Ϫ , and DKO mice were 3:1, 2:1, 3:1, and 1:1, respectively (Fig. 8A) ; 23% and 47% of the CD4 T cells were of the activated/memory phenotype in wt and DKO mice, respectively. Interestingly, phenotypic analysis using CD62L also indicated that the percentage of activated (CD62L lo ) cells among all CD4 T cells in the DKO mice was higher than that in wt mice (Fig. 8B) . Memory T cells can be classified into central memory and effector memory subpopulations based on expression of CD62L; while central memory T cells are CD62L hi , effector memory T cells are CD62L lo (52) . We examined the proportions of central and effector memory cells among memory phenotype (CD44 hi ) CD4 T cells in LCMV-infected wt and TNFR-deficient mice. Note that the dot plots in Fig. 8C are gated on CD44 hi CD4 T cells. The data shown in Fig. 8C indicate that the majority of the CD44 hi CD4 T cells were of the CD62L lo phenotype in all four groups of mice and that the percentages of effector mem- (Fig. 8A ) but were sustained for at least up to 150 days p.i. (Fig. 8D) . The total numbers of naïve CD4 T cells in uninfected DKO mice were comparable to those in wt mice at 8 to 10 weeks of age but dropped considerably by ϳ8 months of age (data not shown). Taken together, these data suggest that TNFRs p55R and p75R might help maintain CD4 T-cell homeostasis in uninfected and LCMV-immune mice by regulating the sizes of the naïve and memory T-cell pools within the CD4 T-cell compartment.
Enhanced LCMV-specific CD4 T-cell memory in TNFR-deficient mice. Recovery from an acute LCMV infection is associated with the development of potent T-cell memory (37, 53, 58) . Here, we examined the effect of TNFR deficiency on the number of virus-specific memory CD4 T cells in LCMV-immune mice. Between days 200 and 250 p.i., the numbers of GP61-specific memory CD4 T cells in the spleens of wt, p55 Ϫ/Ϫ , p75 Ϫ/Ϫ , and DKO mice were quantified using intracellular cytokine staining for IFN-␥ (Fig. 9) . The data shown in Fig. 9A indicate that GP61-specific memory CD4 T cells were detected readily in all groups of mice. The absence of p55R was associated with a modest increase (twofold) in the frequency and total number of GP61-specific memory CD4 T cells in the spleens compared to levels in the spleens of wt mice. Deficiency of p75R alone had no detectable effect on CD4 T-cell memory to LCMV. Notably, there was a striking increase in the total number of GP61-specific memory CD4 T cells in DKO mice compared to the number in wt mice; the number of GP61-specific memory CD4 T cells in the spleens of DKO mice was up to sixfold higher (P Ͻ 0.0001) than the number in the spleens of wt mice (Fig. 9B) . Thus, TNFRs have a role in limiting the number of memory CD4 T cells during an acute viral infection.
Typically, T-cell responses can be divided into three phases: (i) expansion phase, when naïve T cells are activated by an antigen to undergo clonal expansion and differentiation into effector T cells; (ii) contraction phase, when up to 90% of the expanded T cells are lost, presumably by apoptosis; and (iii) memory phase, when a finite number of memory T cells are maintained by cytokine-driven proliferative renewal (48) . The number of memory T cells generated at the termination of an immune response is a function of the extent of primary clonal expansion and the magnitude of the ensuing contraction phase. Therefore, alterations in the expansion and/or the contraction phase can affect the magnitude of T-cell memory. To better understand how TNFRs regulate CD4 T-cell memory, we examined in detail the kinetics of the CD4 T-cell responses in wt and DKO mice following an acute LCMV infection (Fig. 10) . Consistent with the data shown in Fig. 1 , the expansion of GP61-specific CD4 T cells (day 8 p.i.) was higher in DKO mice than in wt mice. Between days 8 and 30 p.i., GP61-specific CD4 T cells in wt and DKO mice showed similar degrees of contraction; approximately 75% of GP61-specific CD4 T cells were lost by contraction in both wt and DKO mice. Between day 30 p.i. and day 106 p.i., there was an additional ϳ60% drop in the numbers of GP61-specific CD4 T cells in both wt and DKO mice. Taken together, these data indicate that TNFRs have a minimal role in regulating the contraction phase of the anti-LCMV CD4 T-cell response. Following expansion, the rates of decrease in the GP61-specific CD4 T cell numbers were the same for DKO mice and wt mice (Fig. 10) . Thus, the significant increase in total GP61-specific CD4 T cells in DKO mice was likely a direct result of the greater clonal burst size (primary expansion) in the absence of TNFR signaling. The increase in the number of GP61-specific memory CD4 T cells in DKO mice was not associated with detectable alterations in the expression of cell surface molecules (CD44, CD11a/CD18, and CD127) or cytokine (IFN-␥, TNF-␣, and IL-2) production ex vivo (data not shown). In conclusion, TNFR deficiency enhanced the "quantity" of CD4 T-cell memory without adversely affecting the "quality" of memory CD4 T cells.
DISCUSSION
Elicitation and maintenance of potent CD4 T-cell responses are of critical importance for defense and development of durable immunity against viral infections. However, the immune regulatory mechanisms that govern CD4 T-cell responses are not well understood. In this study, we have documented for the first time that TNF/TNFR interactions play a negative role in regulating virus-specific CD4 T-cell responses during an acute viral infection. Furthermore, we show that the negative regulatory effects of TNFRs on CD4 T cells are mediated at least in part by indirect effects, possibly via dendritic cells. Importantly, mice deficient in both TNFR I and TNFR II develop substantially greater numbers of memory CD4 T cells without affecting their cell surface phenotype or function. These findings should have clear implications in improving vaccines and treatment of T-cell-dependent immunopathologies.
Previous work that studied the role of TNF/TNFR interactions in regulating T-cell proliferation has provided equivocal results. While one study reported that TNFR I is important for optimal proliferation of alloreactive T cells, another study showed that TNF promotes alloantigen-induced proliferation of CD4 T cells (7, 24) . It has also been suggested that TNFR II signaling provides a costimulatory signal during T-cell activation (27, 28) . In contrast to these studies, TNF exposure seems to reduce proliferation of T cells in vitro due to the inhibition of TCR-induced calcium influx (12) . Studies with mycobacterium infection and experimental autoimmune encephalomyelitis have shown that TNF has a negative role in regulating T-cell responses in vivo (26, 60) . Here, we show that TNFRs I and II have redundant roles in restricting the primary expansion of virus-specific CD4 T cells during an acute LCMV infection. During LCMV infection, the antiproliferative effect of TNF is not restricted to CD4 T cells because primary CD8 T-cell responses are also enhanced in LCMV-infected, TNFRdeficient mice (49) . Thus, depending on the experimental model and the context in which T cells are activated, TNFR signaling might have opposing effects on T-cell proliferation. It is noteworthy that TNF is not required to clear an acute LCMV infection and that the kinetics of LCMV resolution in TNFR-deficient mice is similar to that in wt mice. Therefore, the increased expansion of GP61-specific CD4 T cells in DKO mice is not likely due to a higher viral load.
How do TNFRs suppress expansion of activated CD4 T cells during an acute viral infection? Regulation of CD4 T-cell responses by TNFRs could occur by direct and/or indirect effects. In LCMV-infected mixed bone marrow chimeras, the activation and expansion of TNFR-deficient CD4 T cells were comparable to levels for wt CD4 T cells. Thus, at least in the LCMV model, we found no evidence for direct regulation of CD4 T-cell expansion by TNF. In contrast, TNFR-expressing monoclonal transgenic CD4 T cells expanded more in TNFRdeficient mice than in wt mice, which indicated that TNFR signaling could down regulate CD4 T-cell responses by indirect effects. The magnitude of the T-cell response is dependent upon the duration of antigenic stimulation, which in turn is governed by the life span of dendritic cells (25) . In an acute LCMV infection, cross-priming by CD11c hi dendritic cells is crucial for stimulating CD8 T-cell responses (16) and, quite possibly, CD4 T-cell responses. During an acute LCMV infection, these CD11c hi dendritic cells are rapidly depleted by type I interferons, thereby possibly limiting the duration of T-cell activation (36) . Notably, in our studies, TNFR deficiency reduced the apoptosis of splenocytes and protected against interferon-dependent depletion of CD11c hi dendritic cells in the spleen. Additionally, antigen-driven expansion of adoptively transferred SMARTA T cells was enhanced in TNFR-deficient mice. Our in vivo results are consistent with a recent report that T cell-derived TNF might down regulate dendritic cell viability in vitro (6) . In summary, our results favor the hypothesis that TNFR signaling might regulate the expansion of CD4 T cells by controlling the life span of dendritic cells.
In the context of antiviral immunity, we find that TNFR deficiency results in a marked increase in the number of memory CD4 T cells following an acute LCMV infection. What is the underlying mechanism(s) of enhanced CD4 T-cell memory in DKO mice? The two critical determinants of T-cell memory are (i) the size of the primary response, termed clonal burst size, and (ii) the magnitude of the loss of effector cells during contraction. Our data clearly show that TNFR deficiency increased the clonal burst size of GP61-specific CD4 T cells, with minimal effects on the magnitude of contraction. Additionally, the increase (four-to fivefold) in primary expansion correlates well with the increase in the number of GP61-specific memory CD4 T cells in DKO mice. Although these findings suggest that the primary determinant of enhanced CD4 T-cell memory in DKO mice is the larger clonal burst size, an additional role for TNF-induced apoptosis cannot be excluded (50, 55, 61) . A comprehensive analysis of the rates of proliferation and apoptosis of antigen-specific CD4 T cells in vivo throughout the T-cell response will clarify the mechanism(s).
What are the implications of these findings? In chronic viral infections with hepatitis B virus and hepatitis C virus, viral persistence and disease are associated with poor T-cell responses (30, 31, 33) . Interestingly, the hepatic and/or circulating levels of TNF are high in people with active hepatitis B virus-and hepatitis C virus-induced disease (20, 32, 38) . It is possible that high levels of TNF in these patients might suppress the antiviral T-cell response; therefore, anti-TNF therapies might be beneficial to counteract this suppression. Since the inability to induce a potent T-cell memory might lead to vaccination failures, modulation of TNF activity might improve vaccine-induced T-cell memory and protective immunity. Anti-TNF therapy is commonly used to treat autoimmune disorders, like rheumatoid arthritis (21) . Along with published reports supporting a protective role for TNF in autoimmune disorders (14) , the data presented in this paper urge that caution be exercised before instituting therapies to block the effects of TNF in diseases like rheumatoid arthritis.
